| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |